Chang David J. 4
4 · Cabaletta Bio, Inc. · Filed Jan 19, 2022
Insider Transaction Report
Form 4
Chang David J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-18+135,000→ 135,000 totalExercise: $3.21Exp: 2032-01-17→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on January 18, 2023, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.